TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary

Background & Aims: Crohn’s disease (CD) is a debilitating inflammatory disorder that affects more than 1.6 million people in North America alone. Members of the tumor necrosis factor superfamily are key regulators of intestinal inflammation; specifically, tumor necrosis factor–like weak inducer...

Full description

Bibliographic Details
Main Authors: Luca Di Martino, Abdullah Osme, Sarah Kossak-Gupta, Theresa T. Pizarro, Fabio Cominelli
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Cellular and Molecular Gastroenterology and Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S2352345X19300712
_version_ 1818061731328425984
author Luca Di Martino
Abdullah Osme
Sarah Kossak-Gupta
Theresa T. Pizarro
Fabio Cominelli
author_facet Luca Di Martino
Abdullah Osme
Sarah Kossak-Gupta
Theresa T. Pizarro
Fabio Cominelli
author_sort Luca Di Martino
collection DOAJ
description Background & Aims: Crohn’s disease (CD) is a debilitating inflammatory disorder that affects more than 1.6 million people in North America alone. Members of the tumor necrosis factor superfamily are key regulators of intestinal inflammation; specifically, tumor necrosis factor–like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor–inducible 14 (Fn14), are involved in normal and pathologic tissue remodeling. Our aim was to determine the role of TWEAK/Fn14 in CD and a murine model of CD-like ileitis (ie, SAMP1/YitFc [SAMP] strain). Methods: SAMP mice deficient in Fn14 (SAMP × Fn14-/-) were developed and a detailed time-course study was performed evaluating ileal tissues by histology and stereomicroscopy, as well as quantitative polymerase chain reaction and NanoString technology (Seattle, WA). Reciprocal bone marrow chimeras were generated to assess the relevance of Fn14 in hematopoietic vs nonhematopoietic compartments. Surgically resected intestinal tissues and mucosal biopsy specimens from patients with CD, ulcerative colitis, and healthy controls were analyzed for the expression of TWEAK/Fn14 by quantitative polymerase chain reaction, Western blot, immunohistochemistry, and immunofluorescence. Results: SAMP × Fn14-/- showed a marked decrease in ileitis severity at 20 weeks of age compared with SAMP WT controls. Bone marrow chimeras showed that Fn14 was required in both hematopoietic and nonhematopoietic compartments for ileitis to develop. Transcriptome data showed multiple cellular pathways regulated by Fn14 signaling. Finally, increased expression of TWEAK and Fn14 was observed in tissue lesions from CD patients compared with ulcerative colitis and healthy controls. Conclusions: TWEAK/Fn14 are up-regulated in CD, and also mediate experimental CD-like ileitis, by regulation of multiple innate and adaptive cellular pathways. Therefore, TWEAK/Fn14 may represent a novel therapeutic target for the treatment of small intestinal inflammation in CD. Keywords: Gut Immunity, Intestinal Inflammation, Gene Expression, Proinflammatory Cytokines
first_indexed 2024-12-10T13:52:58Z
format Article
id doaj.art-262d14705fee4fe4ba0278c4a248235f
institution Directory Open Access Journal
issn 2352-345X
language English
last_indexed 2024-12-10T13:52:58Z
publishDate 2019-01-01
publisher Elsevier
record_format Article
series Cellular and Molecular Gastroenterology and Hepatology
spelling doaj.art-262d14705fee4fe4ba0278c4a248235f2022-12-22T01:46:06ZengElsevierCellular and Molecular Gastroenterology and Hepatology2352-345X2019-01-0183427446TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummaryLuca Di Martino0Abdullah Osme1Sarah Kossak-Gupta2Theresa T. Pizarro3Fabio Cominelli4Division of Gastroenterology and Liver Disease, Case Western University School of Medicine, Cleveland, Ohio; Department of Medicine, Case Western University School of Medicine, Cleveland, OhioDivision of Gastroenterology and Liver Disease, Case Western University School of Medicine, Cleveland, Ohio; Department of Medicine, Case Western University School of Medicine, Cleveland, OhioDivision of Gastroenterology and Liver Disease, Case Western University School of Medicine, Cleveland, Ohio; Department of Medicine, Case Western University School of Medicine, Cleveland, OhioDivision of Gastroenterology and Liver Disease, Case Western University School of Medicine, Cleveland, Ohio; Department of Pathology, Case Western University School of Medicine, Cleveland, OhioDivision of Gastroenterology and Liver Disease, Case Western University School of Medicine, Cleveland, Ohio; Department of Medicine, Case Western University School of Medicine, Cleveland, Ohio; Department of Pathology, Case Western University School of Medicine, Cleveland, Ohio; Correspondence Address correspondence to: Fabio Cominelli, MD, PhD, Division of Gastroenterology and Liver Disease, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, Ohio 44106. fax: (216) 368-0647.Background & Aims: Crohn’s disease (CD) is a debilitating inflammatory disorder that affects more than 1.6 million people in North America alone. Members of the tumor necrosis factor superfamily are key regulators of intestinal inflammation; specifically, tumor necrosis factor–like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor–inducible 14 (Fn14), are involved in normal and pathologic tissue remodeling. Our aim was to determine the role of TWEAK/Fn14 in CD and a murine model of CD-like ileitis (ie, SAMP1/YitFc [SAMP] strain). Methods: SAMP mice deficient in Fn14 (SAMP × Fn14-/-) were developed and a detailed time-course study was performed evaluating ileal tissues by histology and stereomicroscopy, as well as quantitative polymerase chain reaction and NanoString technology (Seattle, WA). Reciprocal bone marrow chimeras were generated to assess the relevance of Fn14 in hematopoietic vs nonhematopoietic compartments. Surgically resected intestinal tissues and mucosal biopsy specimens from patients with CD, ulcerative colitis, and healthy controls were analyzed for the expression of TWEAK/Fn14 by quantitative polymerase chain reaction, Western blot, immunohistochemistry, and immunofluorescence. Results: SAMP × Fn14-/- showed a marked decrease in ileitis severity at 20 weeks of age compared with SAMP WT controls. Bone marrow chimeras showed that Fn14 was required in both hematopoietic and nonhematopoietic compartments for ileitis to develop. Transcriptome data showed multiple cellular pathways regulated by Fn14 signaling. Finally, increased expression of TWEAK and Fn14 was observed in tissue lesions from CD patients compared with ulcerative colitis and healthy controls. Conclusions: TWEAK/Fn14 are up-regulated in CD, and also mediate experimental CD-like ileitis, by regulation of multiple innate and adaptive cellular pathways. Therefore, TWEAK/Fn14 may represent a novel therapeutic target for the treatment of small intestinal inflammation in CD. Keywords: Gut Immunity, Intestinal Inflammation, Gene Expression, Proinflammatory Cytokineshttp://www.sciencedirect.com/science/article/pii/S2352345X19300712
spellingShingle Luca Di Martino
Abdullah Osme
Sarah Kossak-Gupta
Theresa T. Pizarro
Fabio Cominelli
TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary
Cellular and Molecular Gastroenterology and Hepatology
title TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary
title_full TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary
title_fullStr TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary
title_full_unstemmed TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary
title_short TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune PathwaysSummary
title_sort tweak fn14 is overexpressed in crohn s disease and mediates experimental ileitis by regulating critical innate and adaptive immune pathwayssummary
url http://www.sciencedirect.com/science/article/pii/S2352345X19300712
work_keys_str_mv AT lucadimartino tweakfn14isoverexpressedincrohnsdiseaseandmediatesexperimentalileitisbyregulatingcriticalinnateandadaptiveimmunepathwayssummary
AT abdullahosme tweakfn14isoverexpressedincrohnsdiseaseandmediatesexperimentalileitisbyregulatingcriticalinnateandadaptiveimmunepathwayssummary
AT sarahkossakgupta tweakfn14isoverexpressedincrohnsdiseaseandmediatesexperimentalileitisbyregulatingcriticalinnateandadaptiveimmunepathwayssummary
AT theresatpizarro tweakfn14isoverexpressedincrohnsdiseaseandmediatesexperimentalileitisbyregulatingcriticalinnateandadaptiveimmunepathwayssummary
AT fabiocominelli tweakfn14isoverexpressedincrohnsdiseaseandmediatesexperimentalileitisbyregulatingcriticalinnateandadaptiveimmunepathwayssummary